Ocular Therapeutix Inc (NASDAQ: OCUL) stock suffered a major decline of -10.8% on 4/1/25. The shares closed at $6.54. Moreover, above average trading volume at 138% of normal accompanied the decline. The stock has been weak relative to the market over the last nine months and has declined -14.2% during the last week.
Current PriceTarget Research Rating
Ocular Therapeutix has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Ocular Therapeutix has a poor Power Rating of 17 and a very low Appreciation Score of 10, and the Lowest Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment